Australia markets closed

Larimar Therapeutics, Inc. (LRMR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
6.65+0.13 (+1.99%)
At close: 04:00PM EDT
6.70 +0.05 (+0.75%)
After hours: 06:48PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
No. of analysts101099
Avg. Estimate-0.37-0.41-1.41-1.92
Low estimate-0.42-0.46-1.51-2.73
High estimate-0.29-0.29-1.2-1.44
Year ago EPS-0.21-0.3-0.84-1.41
Revenue estimateCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
No. of analysts7788
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history29/09/202330/12/202330/03/202429/06/2024
Est. EPS-0.22-0.25-0.23-0.3
Actual EPS-0.21-0.3-0.27-0.34
Difference0.01-0.05-0.04-0.04
Surprise %4.50%-20.00%-17.40%-13.30%
EPS trendCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
Current estimate-0.37-0.41-1.41-1.92
7 days ago-0.38-0.41-1.42-1.99
30 days ago-0.38-0.41-1.41-2.01
60 days ago-0.33-0.36-1.31-1.98
90 days ago-0.33-0.36-1.31-1.98
EPS revisionsCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesLRMRIndustrySector(s)S&P 500
Current qtr.-76.20%N/AN/AN/A
Next qtr.-36.70%N/AN/AN/A
Current year-67.90%N/AN/AN/A
Next year-36.20%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A